Cancer
| 3 min read
Welcome to the April issue of Drug Discovery News. Just eight short months after the termination announcement of Modern Drug Discovery, former MDD executives and editors present you with a unique and exclusive format for industry news.
| 2 min read
Funding boosts capital pool by $11.8 million and adds informatics expertise
| 2 min read
Pall Corp. in late 2004 finalized the $32-million purchase of Ciphergen Biosystems Inc.’s process chromatography sorbent business. The acquisition of the BioSepra Process Division fills a crucial “missing link” in Pall’s extensive fluid management offerin
| 3 min read
Predicant becomes the first company to gain technology rights as Caliper adopts a more expansive out-licensing strategy for its intellectual property estate
